Publication of a collection to specifically look at mental health patients being treated outside their provider of usual treatment. Data covering December 2017.
To evaluate the efficacy and safety of antidepressant augmentation of antipsychotics in schizophrenia.. To read the full article, log in using your SSSFT NHS OpenAthens details. SSOTP - You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
Religiosity is often associated with better health outcomes. The aim of the study was to examine associations between psychotic experiences (PEs) and religiosity in a large, cross-national sample.. To read the full article, log in using your SSSFT NHS OpenAthens details. SSOTP - You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
Daily smoking has been associated with a greater risk of psychosis. However, we are still lacking studies to adjust for baseline psychotic experiences and other substance use. We examined associations between daily smoking and psychosis risk in a 15-year follow-up while accounting for these covariates in a prospective sample (N = 6081) from the Northern Finland Birth Cohort 1986.. To read the full article, log in using your SSSFT NHS OpenAthens details. SSOTP - You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
Depression is associated with accelerated aging and age-related diseases. However, mechanisms underlying this relationship remain unclear. The aim of this study was to longitudinally assess the link between depressive symptoms, brain atrophy, and cortisol levels.. To read the full article, log in using your SSSFT NHS OpenAthens details. SSOTP - You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
This systematic review and meta-analysis of randomized controlled trials (RCTs) examined the efficacy and safety of adjunctive N-acetylcysteine (NAC), an antioxidant drug, in treating major depressive disorder (MDD), bipolar disorder, and schizophrenia.. To read the full article, log in using your SSSFT NHS OpenAthens details. SSOTP - You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
They found that people who ate slower were less likely to be obese; but we don't know from this study whether changing your eating speed would work as a weight-loss strategy.
So, should people wanting to lose weight try to avoid PFAS? That would be difficult, and we don't know whether it would help. We don't know what levels of PFAS chemicals people in the UK have in their bodies. We don't know whether using non-stick cookware, or avoiding food packaging made using PFAS chemicals, would reduce PFAS levels in the body. Without this information, attempting to avoid PFAS chemicals does not seem practical or advisable.
While the Mail Online largely reported the story accurately, it was somewhat over-optimistic about the results – the study was too small and too short to show that a vegan diet prevents diabetes. Also, none of the participants, in either group, had diabetes by the end of the trial.
Despite the authors' efforts, it's very hard to separate someone's diet from the rest of their lifestyle.
We know people who ate more ultra-processed food were more likely to smoke, take less exercise, be less educated and take in more calories.
Other unmeasured aspects of their lives – such as deprivation and access to healthcare – might also have affected the results.
This was an early study which provides the basis for further research. However it is far too soon to know if the test could ever be used in practice. From this single, small study we don't know that it's accurate enough or that it could improve upon existing methods for diagnosing ASD in clinical practice.
Following a recent consultation, the General Medical Council (GMC) has approved the model for a two-part medical licensing assessment (MLA) to be delivered in 2020.
The MLA will provide consistency in the ways that doctors enter UK practice, ensuring they have the required knowledge, skills and professionalism to deliver safe care to patients.